telmisartan has been researched along with cadmium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fouad, AA; Jresat, I | 2 |
| Abdel-Daim, MM; Ahmed, OS; Hassanein, EHM; Mohamed, WR; Sayed, AM | 1 |
1 review(s) available for telmisartan and cadmium
| Article | Year |
|---|---|
The role of inflammation in cadmium nephrotoxicity: NF-κB comes into view.
Topics: Acetylcysteine; Cadmium; Cytochalasin D; Cytokines; Humans; Inflammation; Kidney Diseases; NF-kappa B; Polysaccharides; Sildenafil Citrate; Telmisartan | 2022 |
2 other study(ies) available for telmisartan and cadmium
| Article | Year |
|---|---|
Protective effect of telmisartan against cadmium-induced nephrotoxicity in mice.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Blood Urea Nitrogen; Cadmium; Catalase; Creatine; Fas Ligand Protein; Gene Expression Regulation; Glutathione; Immunohistochemistry; Kidney; Kidney Diseases; Lipid Peroxidation; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Telmisartan; Tumor Necrosis Factor-alpha | 2011 |
Captopril and telmisartan treatments attenuate cadmium-induced testicular toxicity in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cadmium; Cadmium Chloride; Cadmium Poisoning; Captopril; Caspase 3; Fas Ligand Protein; Glutathione; Lipid Peroxidation; Male; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Random Allocation; Rats; Rats, Sprague-Dawley; Selenium; Telmisartan; Testicular Diseases; Testis; Testosterone; Tumor Necrosis Factor-alpha; Zinc | 2013 |